Who We Are

Dr. Rosenfeld is a hematologist who trained at Cornell, Dartmouth and NHLBI. He spent 19 years at NIH doing basic and clinical research and working in medical informatics and hospital administration. He ended his time at the NIH as the Clinical Center’s Chief Information Officer. Dr. Rosenfeld moved from Maryland to Maine, to become the CIO of MaineHealth, a large independent delivery network, before moving to Washington State as the CEO of the Western Institutional Review Board (WIRB). After leaving WIRB he spent 7 years as the Executive Board Chair of Quorum Review. He is currently the President of Freeport Research Systems, LLC and the Executive Director and Review Board Chair of the North Star Review Board. In addition to his medical degree, he holds a master’s in business administration from the Georgetown McDonough School of Business. Dr. Rosenfeld is the immediate past chair of the Secretary’s Advisory Committee on Human Research Protections (SACHRP) and serves on the Boards of Public Responsibility in Medicine and Research (PRIM&R) and the Association for the Accreditation of Human Research Protection Programs (AAHRPP).

---

Ms. Seymour has over 25 years of experience in research and IRB administration

She worked as a Regional Representative and Consultant for Western IRB (WIRB) before becoming their Director of Business Development/Institutions from 2008–2011. Patricia has also served as a Regulatory Analyst and Board Administrator for Quorum Review. During her tenure at WIRB, she served as Interim Director for several major academic medical centers. She has extensive experience drafting standard operating procedures, in the reorganization of IRB offices, in the development and training of managers, staff and board members, and in all aspects of IRB review. She has served as Director of the Human Subject Protection Programs at Columbia, Yale, Boston University and at a joint effort of University Hospitals of Cleveland, Case Western Reserve University and the Cleveland Clinic.  She has contributed to the operations and development of independent review boards including Cambridge Review, Hummingbird IRB and North Star Review Board.

Ms. Seymour has been a speaker at DIA, NCURA, PRIM&R and other conferences. Her international experience includes training investigations and board members for private research companies and sponsors.

---

Barbara E. Bierer, M.D., a hematologist-oncologist, is Professor of Medicine at Harvard Medical School (HMS) and the Brigham and Women’s Hospital (BWH). Dr. Bierer co-founded and now leads the Multi-Regional Clinical Trials Center of BWH and Harvard (MRCT Center), a collaborative effort to improve standards for the planning and conduct of international clinical trials. In this capacity, she works with regulators, pharmaceutical companies, CROs, academia and patients/patient advocates to harmonize policies and approaches for multisite, transnational trials.  She is a co-founder of COVID-19 Collaboration Platform and of the non-profit Vivli, a global clinical research data sharing platform. She is also the Director of the Regulatory Foundations, Ethics, and Law program at the Harvard Catalyst, and Director of Regulatory Policy for SMART IRB. She serves as Faculty in the Center for Bioethics, HMS, and Affiliate Faculty in the Petrie-Flom Center for Health Law at Harvard Law School. From 2003 – 2014, Dr. Bierer served as Senior Vice-President, Research, BWH where she founded the Brigham Research Institute and the Brigham Innovation Hub.  She is a past chair of SACHRP and has served or serves on the Board of Directors of AAHRPP, PRIMR, MSH, Vivli, North Star IRB, and the Edward P. Evans Foundation. She has authored over 250 publications.

---

---